Financhill
Back

Immix Biopharma, Inc. Stock Price Chart

  • The current trend is moderately bullish and IMMX is experiencing slight selling pressure.

Immix Biopharma, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.79 Sell
20-day SMA: 5.57 Buy
50-day SMA: 4.36 Buy
200-day SMA: 2.72 Buy
8-day EMA: 5.81 Sell
20-day EMA: 5.51 Buy
50-day EMA: 4.39 Buy
200-day EMA: 1.91 Buy

Immix Biopharma, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.48 Buy
Relative Strength Index (14 RSI): 55.4 Buy
Chaikin Money Flow: -107495 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.26 - 6.34) Buy
Bollinger Bands (100): (1.92 - 4.68) Buy

Immix Biopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Immix Biopharma, Inc. Stock

Is Immix Biopharma, Inc. Stock a Buy?

IMMX Technical Analysis vs Fundamental Analysis

Buy
52
Immix Biopharma, Inc. (IMMX) is a Buy

Is Immix Biopharma, Inc. a Buy or a Sell?

Immix Biopharma, Inc. Stock Info

Market Cap:
189.4M
Price in USD:
5.64
Share Volume:
511.9K

Immix Biopharma, Inc. 52-Week Range

52-Week High:
7.73
52-Week Low:
1.34
Buy
52
Immix Biopharma, Inc. (IMMX) is a Buy

Immix Biopharma, Inc. Share Price Forecast

Is Immix Biopharma, Inc. Stock a Buy?

Fundamental Analysis of Immix Biopharma, Inc.

Is Immix Biopharma, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.08 per share.

Technical Analysis of Immix Biopharma, Inc.

Should I short Immix Biopharma, Inc. stock?

* Immix Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.